Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway. 2008

W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
Section of Molecular Hematology and Therapy, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Raf/MEK/Erk signaling is activated in the majority of acute myeloid leukemias (AMLs), providing rationale for targeting this pathway with therapeutic intent. We investigated growth-inhibitory and proapoptotic effects of sorafenib in AML. Our studies demonstrated that sorafenib significantly inhibited the phosphorylation levels of Raf downstream target proteins MEK1/2 and Erk, induced apoptosis and inhibited colony formation in AML cell lines and in primary AML samples. Mechanistically, treatment with sorafenib resulted in upregulation of proapoptotic Bim, accompanied by an increase in Bad, Bax and Bak protein levels and decreased Mcl-1, X-linked inhibitor of apoptosis and surviving levels, which mainly led to the activation of the intrinsic apoptotic pathway. Silencing of Bim protein expression significantly abrogated sorafenib-induced apoptosis, suggesting a critical function of Bim in the activation of the intrinsic mitochondrial pathway induced by sorafenib. Importantly, sorafenib also modulated phospho-Erk, Bim, Bax and Mcl-1 levels in samples procured from patients in an ongoing Phase I clinical trial of sorafenib in AML. Combination of sorafenib with cytarabine or the novel small molecule Bcl-2 inhibitor ABT-737 synergistically induced cell death in AML cell lines. Our results strongly suggest potential activity of sorafenib as a novel mechanism-based therapeutic agent in AML.

UI MeSH Term Description Entries
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D008928 Mitochondria Semiautonomous, self-reproducing organelles that occur in the cytoplasm of all cells of most, but not all, eukaryotes. Each mitochondrion is surrounded by a double limiting membrane. The inner membrane is highly invaginated, and its projections are called cristae. Mitochondria are the sites of the reactions of oxidative phosphorylation, which result in the formation of ATP. They contain distinctive RIBOSOMES, transfer RNAs (RNA, TRANSFER); AMINO ACYL T RNA SYNTHETASES; and elongation and termination factors. Mitochondria depend upon genes within the nucleus of the cells in which they reside for many essential messenger RNAs (RNA, MESSENGER). Mitochondria are believed to have arisen from aerobic bacteria that established a symbiotic relationship with primitive protoeukaryotes. (King & Stansfield, A Dictionary of Genetics, 4th ed) Mitochondrial Contraction,Mitochondrion,Contraction, Mitochondrial,Contractions, Mitochondrial,Mitochondrial Contractions
D009536 Niacinamide An important compound functioning as a component of the coenzyme NAD. Its primary significance is in the prevention and/or cure of blacktongue and PELLAGRA. Most animals cannot manufacture this compound in amounts sufficient to prevent nutritional deficiency and it therefore must be supplemented through dietary intake. Nicotinamide,Vitamin B 3,Vitamin PP,3-Pyridinecarboxamide,Enduramide,Nicobion,Nicotinsäureamid Jenapharm,Papulex,Vitamin B3,3 Pyridinecarboxamide,B 3, Vitamin,B3, Vitamin,Jenapharm, Nicotinsäureamid
D010671 Phenylurea Compounds Compounds that include the amino-N-phenylamide structure. Phenylcarbamides,Phenylurea Derivatives,Compounds, Phenylurea,Derivatives, Phenylurea
D011518 Proto-Oncogene Proteins Products of proto-oncogenes. Normally they do not have oncogenic or transforming properties, but are involved in the regulation or differentiation of cell growth. They often have protein kinase activity. Cellular Proto-Oncogene Proteins,c-onc Proteins,Proto Oncogene Proteins, Cellular,Proto-Oncogene Products, Cellular,Cellular Proto Oncogene Proteins,Cellular Proto-Oncogene Products,Proto Oncogene Products, Cellular,Proto Oncogene Proteins,Proto-Oncogene Proteins, Cellular,c onc Proteins
D011725 Pyridines Compounds with a six membered aromatic ring containing NITROGEN. The saturated version is PIPERIDINES.
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072224 Bcl-2-Like Protein 11 A BCL-2-like protein that has a C-terminal BCL-2 homology (BH3) domain and forms heterodimers with other BCL-2 FAMILY PROTEINS. It is a strong inducer of APOPTOSIS and ANOIKIS; several isoforms are expressed (BimEL, Bim L, Bim-alpha, Bim-s; and Bim-gamma) that have different potencies for inducing apoptosis. BCL2L11 Protein,BIM Protein,Bcl-2-Binding Protein, BIM,Bcl-2-Interacting Mediator of Cell Death,11, Bcl-2-Like Protein,BIM Bcl-2-Binding Protein,Bcl 2 Binding Protein, BIM,Bcl 2 Interacting Mediator of Cell Death,Bcl 2 Like Protein 11,Protein 11, Bcl-2-Like,Protein, BCL2L11,Protein, BIM,Protein, BIM Bcl-2-Binding

Related Publications

W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
August 2015, Apoptosis : an international journal on programmed cell death,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
January 2013, Biochemical pharmacology,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
January 2018, Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
November 2020, Molecular medicine reports,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
May 2004, Leukemia,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
June 2020, Toxicology in vitro : an international journal published in association with BIBRA,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
April 2011, Zhongguo shi yan xue ye xue za zhi,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
April 2014, Genetics and molecular research : GMR,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
May 2012, Cellular signalling,
W Zhang, and M Konopleva, and V R Ruvolo, and T McQueen, and R L Evans, and W G Bornmann, and J McCubrey, and J Cortes, and M Andreeff
January 2018, Oxidative medicine and cellular longevity,
Copied contents to your clipboard!